Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-019525·Drugs Made In America Acquisition Corp.
Schedule 13D ownership disclosure
DRUGS MADE IN AMER ACQUTN CO
Ordinary Shares · CUSIP: G2847J104
Event date: 2025-02-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Drugs Made In America Acquisition LLCReported CIK 0002038492
Shares: 4,188,780.00 · Class: 12.5%
- Lynn StockwellReported CIK 0001927032
Shares: 4,188,780.00 · Class: 12.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-019525
- Form type
- SCHEDULE 13D
- Filer
- Drugs Made In America Acquisition Corp.
- CIK
- CIK 2028614
- Filed
- Mar 03, 2025
- Reporting period
- Feb 18, 2025
- Description
- Schedule 13D beneficial ownership